Novo Nordisk (NVO) PT Lowered to $105 at BMO Capital

December 23, 2024 8:21 AM EST Send to a Friend
(Updated - December 23, 2024 8:22 AM EST)

BMO Capital analyst Evan David Seigerman lowered the price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login